Skip to main content
Log in

Cianopramine and amitriptyline in the treatment of depressed patients — a placebo-controlled study

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

3-Cyano-imipramine (cianopramine) is a potent and selective inhibitor of serotonin uptake into synaptosomes. In a double-blind trial, 60 patients with various types of depression fulfilling the DSM-III criteria of depressive episodes were treated with either cianopramine (n=20, mean daily dose 3.3±0.6 mg) amitriptyline (n=20, mean daily dose 86.4±21 mg) or placebo (n=20) orally. According to the ratings of the Hamilton Scale of Dpression and clinical global evaluations, both active drugs showed statistical superiority over placebo (P<0.02). The frequencies of anticholinergic side effects in the cianopramine group were comparable to those of the placebo group and were less than in the amitriptyline group. The findings suggest that cianopramine is a promising new antidepressant.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Da Prada M, Keller HH, Burkard WP, Schaffner R, Bonetti EP, Launay JM, Haefely W (1982) Some neuropharmacological effects of cianopramine — A novel tricyclic antidepressant with potent inhibitory activity in the uptake of 5-HT. In Costa E, Racagni G (eds) Typical and atypical antidepressant: Molecular mechanism. Raven Press, New York, pp 235–247

    Google Scholar 

  • Gasic S, Korn A, Omer LMO (1982) Cardiocirculatory effects of Ro 11-2465, a selective 5-HT (serotonin) uptake inhibitor, in healthy volunteers. Eur J Clin Pharmacol 21:357–361

    Google Scholar 

  • Guy W (1976) ECDEU assessment manual or psychopharmacology, U.S. Department of Health, Education and Welfare Publication No (ADM) 76-3381

  • Kenny M, Lenehan TJ, Lambe R, Darragh A, Brick I, Omer LMO (1983) Effects of a single oral dose of 3-ciano-imipramine on serotonin uptake and content of platelets in healthy volunteers. Psychopharmacology 79:302–307

    Google Scholar 

  • Lenehan T, Omer LMO, Darragh A (1981a) Effect of cianopramine, a new psychoactive agent on the uptake of serotonin by human platelets-in-vitro determination of the IC50. Arch Int Pharmacodyn Ther 249:147–152

    Google Scholar 

  • Lenehan T, Omer LMO, Kenny M, Lambe R, Darragh A (1981b) The effects of multiple rising doses of cianopramine (serotonin uptake inhibitor) on serotonin content of human platelets. Psychopharmacology 74:1–3

    Google Scholar 

  • Mann HB, Whitney DR (1947) On a test of whether one of two random variables is stochastically larger than the other. Ann Math Statist 18:50–60

    Google Scholar 

  • Van Praag HM (1982) Depression, suicide and the metabolism of serotonin in the brain. J Affect Dis 4:291–298

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hormazabal, L., Omer, L.M.O. & Ismail, S. Cianopramine and amitriptyline in the treatment of depressed patients — a placebo-controlled study. Psychopharmacology 86, 205–208 (1985). https://doi.org/10.1007/BF00431710

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00431710

Key words

Navigation